Key result
Among diabetic patients who fulfilled the Endocrine Society criteria for primary aldosteronism screening, only 23.3% (14 of 60) were actually screened using the aldosterone-to-renin ratio.
Why the study?
Hypertension is common in patients with type 2 diabetes who carry increased cardiovascular risk, but it is unknown how frequently they are tested for primary aldosteronism.
Are patients with diabetes and hypertension adequately screened for primary aldosteronism according to guidelines?
Population
272 patients who attended tertiary diabetes clinics with two or more blood pressure measurements
Comparison
Patients who met primary aldosteronism screening criteria vs those who did not
Design
Retrospective cohort study
Authors
Loading...
PA screening rates remain low despite indications in diabetes clinics; leaves open the need for targeted implementation strategies in this population.
Cohort (n=272)
Are patients with diabetes and hypertension adequately screened for primary aldosteronism according to guidelines?
Only a minority of diabetic patients who fulfill criteria for primary aldosteronism screening are actually screened in tertiary care, indicating a significant gap in clinical practice.
Tan et al. (2022) conducted a cohort in Type 2 diabetes (n=272). Indication for primary aldosteronism screening vs. No indication for screening was evaluated on Screening for primary aldosteronism using the aldosterone-to-renin ratio. Among diabetic patients who fulfilled the Endocrine Society criteria for primary aldosteronism screening, only 23.3% (14 of 60) were actually screened using the aldosterone-to-renin ratio.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: